Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA-MERS-S_DF-1 vaccine in healthy adults
NCT04119440Phase 1Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Apr 2021
- Primary completion
- Nov 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of MVA-MERS-S in Middle East respiratory syndrome (MERS), sponsored by University Medical Center Hamburg-Eppendorf. Started Apr 2021; status: completed.
02
Drugs
MVA-MERS-S
03
Conditions
Middle East respiratory syndrome (MERS)
Beyond the preview
Go deeper on NCT04119440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04119440.